Name: Oral Complications of Cancer Chemotherapy (en Inglés)
Price: 655334.00 COP
Availability: InStock
Author: Peterson, Douglas E. ; Sonis, Stephen T.
ISBN: 9781461339144

portada Oral Complications of Cancer Chemotherapy (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Peterson, Douglas E. ; Sonis, Stephen T.

Idioma

Inglés

N° páginas

186

Encuadernación

Tapa Blanda

Dimensiones

22.9 x 15.2 x 1.1 cm

Peso

0.29 kg.

ISBN13

9781461339144

Categorías

Oncología
Jardinería

Oral Complications of Cancer Chemotherapy (en Inglés)

Peterson, Douglas E. ; Sonis, Stephen T. (Autor) · Springer · Tapa Blanda

Libro Nuevo

$ 655.334

$ 1.310.669

Ahorras: $ 655.334

50% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Martes 06 de Agosto y el Martes 20 de Agosto.

Lo recibirás en cualquier lugar de Colombia entre 1 y 5 días hábiles luego del envío.

Reseña del libro "Oral Complications of Cancer Chemotherapy (en Inglés)"

This new work on oral complications of cancer chemotherapy is edited by two dentists who have made pioneering contributions in this previously neglected area. Their efforts have established the invaluable role of the dentist in oncologic research and cancer patient management. The editors have collected nine chapters that will be of interest to dentists and dental hygienists, oncology nurses, and all physicians treating cancer patients with chemo- therapeutic agents. Background chapters on oral complications of cancer chemotherapy, the pharmacology of chemotherapeutic agents, and principles of infection management and prevention set the stage for more specific chapters focusing on prevention and treatment of chemotherapy- induced oral and dental disorders. Valuable contributions to the supportive care of the cancer patient are contained in this book. A full comprehension of this book, coupled with an appreciation for advances in other areas of supportive care, such as antiemetic therapy and pain control, will allow all those involved in cancer treatment to be more successful. Peter H. Wiernik, M.D. Emil Frei, M.D.